In an industry-first, the company Synchron and Mount Sinai Hospital in New York have enrolled their first human patient in a U.S. clinical trial called COMMAND to evaluate an endovascular ...
Cold Fusion on MSN
Elon Musk put a Neuralink chip in a 29-year-old man’s brain - then something went wrong
Elon Musk’s Neuralink has dominated the brain-computer interface conversation for years, but the transcript shows that rivals ...
Synchron, a New York, NY-based manufacturer of non-surgical brain-computer interface technology, said it has raised a $200 million series D round. The funds are expected to accelerate ...
The round was led by Double Point Ventures, alongside existing investors ARCH Ventures, Khosla Ventures, Bezos Expeditions, NTI and METIS. New investors include the Australian National Reconstruction ...
Synchron Inc. raised $200 million to advance its work building brain implants that doctors can insert through blood vessels, ...
The number of people with electrodes in their brains is believed to have more than doubled in the last couple of years. This week, I covered the story of Casey Harrell—a man with ALS who is “the first ...
Brain-computer interfaces rely on electrodes to gather enough signal. But the materials and strategies can vary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results